A study of BION-1301 in the treatment of multiple myeloma

Trial Profile

A study of BION-1301 in the treatment of multiple myeloma

Planning
Phase of Trial: Phase I

Latest Information Update: 01 Mar 2017

At a glance

  • Drugs BION 1301 (Primary)
  • Indications Multiple myeloma
  • Focus Adverse reactions
  • Most Recent Events

    • 01 Mar 2017 According to an Aduro Biotech media release, the company is planning to initiate this trial in the second half of 2017
    • 04 May 2016 New trial record
    • 28 Apr 2016 According to an Aduro Biotech media release, the company is planning to initiate this trial in the year 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top